Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer

TA1108 - FDG (PDF 258 KB)

TA1108 - FDG committee papers (PDF 2.61 MB)

TA1108 - ACM2 meeting slides (PDF 1.49 MB)

TA1108 - DG (PDF 276 KB)

TA1108 - DG committee papers (PDF 7.03 MB)

TA1108 - ACM1 presentation slides (PDF 1.1 MB)

TA1108 - Final scope (PDF 183 KB)

TA1108 - stakeholder list (PDF 178 KB)

Final draft guidance

Final draft guidance (PDF 266 KB)

Committee papers (PDF 538 KB)